In addition, in KICH and LIHC, SRSF3 is significantly co-expressed with more immune checkpoint genes, indicating that SRSF3 is easier to regulate tumor immune response by regulating immune checkpoint activity in these three malignant tumors. The gene discussed is SRSF3; the disease is neoplasm.